CompletedNot Applicable

Mapping of Lymph Node Metastasis and Survival For pN+ Superficial Esophageal Squamous Cell Carcinoma

207 participantsStarted 2012-02-01

Plain-language summary

With the deeper tumor invasion, the higher LNM rate beside the bilateral recurrent laryngeal nerves(RLN) was.

Who can participate

Age range44 Years – 73 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Our predefined search strategy identified pT1N+ ESCC cases without preoperative treatment, between February 2012 and April 2022. Exclusion Criteria: * The patients were excluded because they were (1)less than 10 lymph nodes removed; (2) lacked specific sites of LNM; or (3) incomplete follow-up information.

What they're measuring

LNM rates of the 207 thoracic T1N+ ESCC patients.

Timeframe: 2012.2-2022.4

Trial details

NCT IDNCT05526456

SponsorNational Cancer Center, China

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04-30

View on ClinicalTrials.gov More National Cancer Center/Cancer Hospital trials